Embecta (EMBC) Capital Expenditures Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | -11.41% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 9.65% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 61.83% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | -63.39% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 14.32% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 21.73% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 12.30% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 15.01% |
| 10 | Embecta | 197.17 Mn | 3.77 Mn | 127.80 Mn | 400.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 400.00% |
| Dec 31, 2025 | -60.00% |
| Jun 30, 2025 | -95.88% |
| Mar 31, 2025 | -97.06% |
| Dec 31, 2024 | -44.44% |
| Jun 30, 2024 | 42.65% |
| Mar 31, 2024 | -41.38% |
| Dec 31, 2023 | -42.55% |
| Sep 30, 2023 | 6.98% |
| Jun 30, 2023 | 28.30% |
| Mar 31, 2023 | 7.41% |
| Dec 31, 2022 | 9.30% |
| Sep 30, 2022 | -32.81% |
| Jun 30, 2022 | -28.38% |
| Mar 31, 2022 | 3.85% |
| Dec 31, 2021 | -62.28% |